理研ビタミン株式会社 2026年3月期業績予想修正のお知らせ

This document announces the revision of the consolidated earnings forecast for the fiscal year ending March 2026 by RIKEN VITAMIN Co., Ltd. The revision is due to a significant decline in sales and operating profit in overseas operations, influenced by sluggish consumption in China and intensified price competition in Europe and Southeast Asia. Additionally, a change in the estimation of asset retirement obligations related to asbestos removal has negatively impacted domestic food business profits. The revised forecast indicates sales of 96,000 million yen, operating profit of 6,200 million yen, ordinary profit of 7,000 million yen, and net profit attributable to parent shareholders of 6,500 million yen. There are no changes to the year-end dividend forecast.